What is the prevalence of Skin Cancer?

Skin cancer is the most common form of cancer globally, with millions of new cases diagnosed annually, though rates vary significantly by geographic location and ultraviolet (UV) exposure. While non-melanoma skin cancer is highly prevalent, rarer forms like ocular or mucosal melanoma are considered rare diseases, often leading to challenges in tracking exact global prevalence.

How common is skin cancer?

In the United States alone, the American Academy of Dermatology estimates that one in five Americans will develop skin cancer in their lifetime. Because the vast majority of non-melanoma skin cancers (basal and squamous cell carcinomas) are not tracked by national cancer registries in the same way as other malignancies, true prevalence is likely much higher than official statistics suggest. Within the DiseaseMaps.org community, 34 individuals have shared their experiences, highlighting the diverse patient journey across different types of skin cancer.

What are the primary factors influencing prevalence?

The incidence of skin cancer is heavily influenced by environmental and biological factors, including:

• Geographic Location: Proximity to the equator and high-altitude regions correlate with higher UV radiation exposure and increased skin cancer rates.


• Ethnicity and Skin Tone: Fairer skin types (Fitzpatrick types I and II) are at a higher statistical risk, though skin cancer occurs across all ethnic groups and can be frequently misdiagnosed in darker skin tones.


• Gender Distribution: Historically, men have higher rates of skin cancer, often attributed to higher occupational sun exposure, though this gap is narrowing.


• Age of Onset: While pediatric cases are rare, the risk of skin cancer increases sharply with age, with most diagnoses occurring in adults over age 50.

Why is accurate skin cancer data challenging to collect?

Tracking the prevalence of skin cancer is difficult because many cases are treated in outpatient clinics rather than hospitals, often bypassing formal cancer reporting systems. Underdiagnosis remains a significant issue, particularly for rare or aggressive forms like melanoma, where early detection is critical but not always achieved. Patient-reported data from platforms like DiseaseMaps.org provides a vital, complementary perspective that helps bridge the gap between clinical statistics and the lived experience of those managing skin cancer.

Next steps

• Schedule an annual full-body skin examination with a board-certified dermatologist.


• Perform monthly skin self-exams to monitor for changing moles or non-healing sores.


• Join the DiseaseMaps.org community to connect with others sharing their unique experiences with skin cancer.


• Utilize resources from the Skin Cancer Foundation for guidance on sun safety and early detection.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always consult with a qualified healthcare provider regarding your health concerns.

References

• American Academy of Dermatology (AAD): Skin Cancer Statistics.


• National Cancer Institute (NCI) SEER Program: Cancer Stat Facts.


• World Health Organization (WHO): Skin Cancer Prevention and Incidence Data.


• The Skin Cancer Foundation: Skin Cancer Facts and Figures.